Cargando…

Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report

BACKGROUND: Giant Cell Arteritis (GCA) is a large vessel vasculitis that most commonly presents with headache, scalp tenderness, jaw claudication, and vision changes. Various other, less common, manifestations have been reported in the literature such as scalp and tongue necrosis. Though most patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Young Min, El Khoury, Lara, Paramo, Jonathan, Horowitz, Diane Michelle, Li, Jian Yi, Kello, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184098/ https://www.ncbi.nlm.nih.gov/pubmed/37189114 http://dx.doi.org/10.1186/s12891-023-06465-z

Ejemplares similares

Giant Cell Arteritis With Chronic Bronchitis Successfully Treated With Tocilizumab
por: Ohta, Ryuichi, et al.
Publicado: (2023)

Tongue Necrosis: An Atypical Sign of Giant-cell Arteritis
por: Tago, Masaki, et al.
Publicado: (2021)

Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review
por: Sobrinho, Rafael Alex Barbosa de Siqueira, et al.
Publicado: (2017)

Giant cell arteritis presenting with progressive dysphagia and tongue necrosis
por: Payen, Caroline, et al.
Publicado: (2022)

Vision loss in patients with giant cell arteritis treated with tocilizumab
por: Amsler, Jennifer, et al.
Publicado: (2021)

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
por: Hara, Kazusato, et al.
Publicado: (2021)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

Bitemporal Scalp, Lip and Tongue Necrosis in Giant Cell Arteritis: A Rare Presentation
por: Kumar, Rajesh, et al.
Publicado: (2013)

Tongue Necrosis as an Initial Manifestation of Giant Cell Arteritis: Case Report and Review of the Literature
por: Zaragoza, Jose R., et al.
Publicado: (2015)

Tongue necrosis in a patient with cranial arteritis
por: Maahs, Gerson Schulz, et al.
Publicado: (2015)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
por: Seitz, Luca, et al.
Publicado: (2021)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
por: Saha, Pratyasha, et al.
Publicado: (2022)

Giant Cell Arteritis Presenting as Scalp Necrosis
por: Maidana, Daniel E., et al.
Publicado: (2011)

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
por: Loricera, Javier, et al.
Publicado: (2022)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2021)

Scalp Necrosis Revealing Severe Giant-Cell Arteritis
por: Idoudi, Safa, et al.
Publicado: (2020)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

55. A case for continuing tocilizumab beyond 12 months in giant cell arteritis?
por: Ming, Caroline, et al.
Publicado: (2019)

Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
por: Butryn, Michaela, et al.
Publicado: (2021)

Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis
por: Matza, Mark A, et al.
Publicado: (2023)

Scalp Necrosis as a Late Sign of Giant-Cell Arteritis
por: Alimohammadi, Mohammad, et al.
Publicado: (2013)

Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody
por: Lurati, Alfredomaria, et al.
Publicado: (2012)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
por: Conticini, Edoardo, et al.
Publicado: (2020)

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
por: de Boysson, Hubert, et al.
Publicado: (2021)

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
por: Strand, Vibeke, et al.
Publicado: (2019)

Delayed Diagnosis of Giant Cell Arteritis in the Setting of Isolated Lingual Necrosis
por: DeBord, Logan Christopher, et al.
Publicado: (2019)

Tozinameran: Bilateral giant cell arteritis with skin necrosis: case report
Publicado: (2022)

Clinical Images: Tongue ulceration in giant cell arteritis associated with asymptomatic retinal ischemia
por: Guarda, Max, et al.
Publicado: (2023)

Perioperative Management of Takayasu Arteritis for Cardiac Surgery in a Patient Treated With Tocilizumab
por: Arita, Yoh, et al.
Publicado: (2020)

Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022)

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
por: Unizony, Sebastian, et al.
Publicado: (2021)

Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
por: Regola, Francesca, et al.
Publicado: (2020)

Stevens Johnson Syndrome in a Patient with Giant Cell Arteritis During Short Term Tocilizumab Therapy
por: Venkateswaran, Niranjani, et al.
Publicado: (2020)

A successful antenatal outcome in a patient with refractory Takayasu’s arteritis treated with tocilizumab throughout pregnancy—a case report
por: Khan, Behram, et al.
Publicado: (2023)

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension
por: Stone, John H, et al.
Publicado: (2021)

Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
por: Stone, John H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bvg91lop7v36duqgksf8g5e1bv